Top Oncologist Named Chair of the Department of Medicine
At Michigan, Lippman is the John G. Searle Professor and Chair of Internal Medicine and a Professor of Pharmacology. Before joining the university in 2001, Lippman spent 13 years at Georgetown University in Washington, D.C., where he was Director of the Vincent T. Lombardi Cancer Research Center and Chairman of Oncology. He also spent 18 years as a senior investigator at the National Cancer Institute.
“It is very rare to have the opportunity to recruit as chairman of medicine the chair of a department that ranks in the top 10 in the nation,” said Pascal J. Goldschmidt, M.D., senior vice president for medical affairs and dean of the UM Miller School of Medicine. “Marc Lippman is probably the best chair of medicine currently in the position, and his talent as a clinician, his teaching ability and his research acumen are second to none.
“He has made extraordinary contributions to the field of breast cancer detection, prevention, treatment and even cure, and as such he is one of the most renowned oncologists in the U.S. and internationally.”
Lippman was a pioneer in studying the role of estrogen in breast cancer and developed the first system that allowed researchers to stimulate cells with estrogen outside the body, a breakthrough that allowed extensive testing of estrogen at the molecular level. He is currently working on a biological marker that could predict which breast tumors will respond to hormone therapy, and he has long been interested in building bridges between laboratory scientists and physicians who see patients.
“The University of Miami exactly fits my views of what I want to do,” said Lippman. “There are a tremendous number of the pieces of the puzzle already in place at the UM Miller School of Medicine to create a wonderful entity – great leadership, great facilities, a real desire to continue to improve.”
Lippman will continue his breakthrough research in breast oncology and continue to see patients in addition to his duties as chairman. “I definitely will continue to have a lab and I am hopeful that several researchers who have collaborated with me for a number of years will be joining me in Miami,” he said. “I feel that as the chair of medicine, it is important for me to be doing all the things that my faculty members do. It can only make me a better leader and faculty member.”
Dr. Lippman is familiar with a number of UM faculty members. He has already met with Dr. Jerry Goodwin and Dr. Joseph Rosenblatt, leaders at the University of Miami Sylvester Comprehensive Cancer Center. “One of my most important mandates will be to improve every aspect of oncology services and research,” said Lippman. “We anticipate many other recruits joining us at the UM Miller School and UM/Sylvester.”
He also considered Dr. William O’Neill a “friendly rival” before O’Neill took over clinical operations at UM from the William Beaumont Hospital in Royal Oak, Michigan, and he knew UM President Donna E. Shalala from their years together in Washington.
As a departmant chair, Lippman will also be Chief of Medicine at Jackson Memorial Hospital, the main teaching hospital for the Miller School of Medicine.
Lippman graduated with honors from Cornell University and earned his medical degree at Yale. He rose to the rank of Medical Director of the U.S. Public Health Service during his time at NIH and reached the rank of Captain in the U.S. Naval Reserve. He has lectured throughout the United States and in Israel and Canada, holds five patents, and has authored more than 600 articles, chapters and books.
Dr. Lippman will relocate to Miami with his wife and he’s looking forward to indulging in a couple of favorite hobbies – scuba diving and underwater photography.
He believes UM is poised to help revolutionize the practice of medicine. “In the coming years, folks from around the country will watch our progress and they’ll be asking, why didn’t I see that?” Lippman starts May 1.